4.6 Article

Genome-Wide Association Study with Targeted and Non-targeted NMR Metabolomics Identifies 15 Novel Loci of Urinary Human Metabolic Individuality

Journal

PLOS GENETICS
Volume 11, Issue 9, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pgen.1005487

Keywords

-

Funding

  1. German Ministry of Education and Research (BMBF) [01ZZ9603, 01ZZ0103, 01ZZ0403]
  2. University Medicine Greifswald
  3. Siemens Healthcare, Erlangen, Germany
  4. Federal State of Mecklenburg-West Pomerania
  5. BMBF [03ZIK012]
  6. Helmholtz Zentrum Munchen - German Research Center for Environmental Health
  7. Federal State of Bavaria
  8. Munich Center of Health Sciences (MC Health)
  9. Ludwig-Maximilians-Universitat, as part of LMUinnovativ
  10. Helmholtz Cross Program Activity Metabolic Dysfunction and Human Diseases
  11. GANI_MED project - BMBF
  12. State of Mecklenburg-West Pomerania [03IS2061A]
  13. Swiss Institute of Bioinformatics
  14. Swiss National Science Foundation [FN310030_152724/1]
  15. Helmholtz Cross Program Initiative Personalized Medicine (iMed)
  16. Biomedical Research Program funds at Weill Cornell Medical College in Qatar - Qatar Foundation

Ask authors/readers for more resources

Genome-wide association studies with metabolic traits (mGWAS) uncovered many genetic variants that influence human metabolism. These genetically influenced metabotypes (GIMs) contribute to our metabolic individuality, our capacity to respond to environmental challenges, and our susceptibility to specific diseases. While metabolic homeostasis in blood is a well investigated topic in large mGWAS with over 150 known loci, metabolic detoxification through urinary excretion has only been addressed by few small mGWAS with only 11 associated loci so far. Here we report the largest mGWAS to date, combining targeted and non-targeted H-1 NMR analysis of urine samples from 3,861 participants of the SHIP-0 cohort and 1,691 subjects of the KORA F4 cohort. We identified and replicated 22 loci with significant associations with urinary traits, 15 of which are new (HIBCH, CPS1, AGXT, XYLB, TKT, ETNPPL, SLC6A19, DMGDH, SLC36A2, GLDC, SLC6A13, ACSM3, SLC5A11, PNMT, SLC13A3). Two-thirds of the urinary loci also have a metabolite association in blood. For all but one of the 6 loci where significant associations target the same metabolite in blood and urine, the genetic effects have the same direction in both fluids. In contrast, for the SLC5A11 locus, we found increased levels of myo-inositol in urine whereas mGWAS in blood reported decreased levels for the same genetic variant. This might indicate less effective re-absorption of myo-inositol in the kidneys of carriers. In summary, our study more than doubles the number of known loci that influence urinary phenotypes. It thus allows novel insights into the relationship between blood homeostasis and its regulation through excretion. The newly discovered loci also include variants previously linked to chronic kidney disease (CPS1, SLC6A13), pulmonary hypertension (CPS1), and ischemic stroke (XYLB). By establishing connections from gene to disease via metabolic traits our results provide novel hypotheses about molecular mechanisms involved in the etiology of diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available